232 related articles for article (PubMed ID: 25030421)
1. Aberrant host defense against Leishmania major in the absence of SLPI.
McCartney-Francis N; Jin W; Belkaid Y; McGrady G; Wahl SM
J Leukoc Biol; 2014 Nov; 96(5):917-29. PubMed ID: 25030421
[TBL] [Abstract][Full Text] [Related]
2. Resistance Against
Lopes ME; Dos Santos LM; Sacks D; Vieira LQ; Carneiro MB
Front Immunol; 2021; 12():730437. PubMed ID: 34745100
[TBL] [Abstract][Full Text] [Related]
3. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
Anderson CF; Mendez S; Sacks DL
J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
[TBL] [Abstract][Full Text] [Related]
4. Persistence of lesions in suppressor of cytokine signaling-1-deficient mice infected with Leishmania major.
Bullen DV; Baldwin TM; Curtis JM; Alexander WS; Handman E
J Immunol; 2003 Apr; 170(8):4267-72. PubMed ID: 12682261
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function.
Whyte CS; Bishop ET; Rückerl D; Gaspar-Pereira S; Barker RN; Allen JE; Rees AJ; Wilson HM
J Leukoc Biol; 2011 Nov; 90(5):845-54. PubMed ID: 21628332
[TBL] [Abstract][Full Text] [Related]
6. RANK Ligand Helps Immunity to
Rigoni TS; Vellozo NS; Cabral-Piccin M; Fabiano-Coelho L; Lopes UG; Filardy AA; DosReis GA; Lopes MF
Front Immunol; 2020; 11():886. PubMed ID: 32477357
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-Dependent Recruitment of CD4(+) T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection.
Carneiro MB; Lopes ME; Vaz LG; Sousa LM; dos Santos LM; de Souza CC; Campos AC; Gomes DA; Gonçalves R; Tafuri WL; Vieira LQ
J Interferon Cytokine Res; 2015 Dec; 35(12):935-47. PubMed ID: 26401717
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
10. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice.
Xu G; Liu D; Fan Y; Yang X; Korner H; Fu YX; Uzonna JE
J Immunol; 2007 Oct; 179(8):5358-66. PubMed ID: 17911622
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
14. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
[TBL] [Abstract][Full Text] [Related]
15. Control of Leishmania major infection in mice lacking TNF receptors.
Nashleanas M; Kanaly S; Scott P
J Immunol; 1998 Jun; 160(11):5506-13. PubMed ID: 9605154
[TBL] [Abstract][Full Text] [Related]
16. Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with
Hu S; Marshall C; Darby J; Wei W; Lyons AB; Körner H
Front Immunol; 2018; 9():1. PubMed ID: 29403488
[TBL] [Abstract][Full Text] [Related]
17. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
18. All-
Vellozo NS; Pereira-Marques ST; Cabral-Piccin MP; Filardy AA; Ribeiro-Gomes FL; Rigoni TS; DosReis GA; Lopes MF
Front Immunol; 2017; 8():1560. PubMed ID: 29204144
[TBL] [Abstract][Full Text] [Related]
19. Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing.
Mylonas KJ; Nair MG; Prieto-Lafuente L; Paape D; Allen JE
J Immunol; 2009 Mar; 182(5):3084-94. PubMed ID: 19234205
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA
Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
